Affinity Wealth Management LLC Amicus Therapeutics, Inc. Transaction History

Affinity Wealth Management LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 17, 2021	SELL	$9.2 - $23.86 $1.26 Million - $3.27 Million	-136,952 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$13.47 - $24.89 $46,444 - $85,820	3,448 Added 2.58%	136,952 $2.99 Million
Q3 2020 Nov 16, 2020	BUY	$12.89 - $15.89 $133,037 - $164,000	10,321 Added 8.38%	133,504 $1.92 Million
Q2 2020 Aug 13, 2020	BUY	$8.86 - $15.69 $1.09 Million - $1.93 Million	123,183 New	123,183 $1.78 Million

312

314M

516K

833K

Ticker FOLD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 280,497,984
Market Cap $2.75B
Description
Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...

Get notified when there are updates to the investment portfolio of Affinity Wealth Management LLC, based on Form 13F filings with the SEC.

Stay updated on Affinity Wealth Management LLC with notifications on news.